Berberine has the potential to improve radiosensitivity in nasopharyngeal carcinoma by inhibiting EMT and suppressing TGF‐β1, which downregulates the expression of specific protein 1 (Sp1) [67]. The gene discussed is SP1; the disease is nasopharyngeal carcinoma.